Jackson Financial Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
JXN$138.01+1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Loss)
| For the Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net income (loss) | $954 | $6,229 | $3,679 |
| Other comprehensive income (loss), net of tax: | |||
| Change in unrealized gains (losses) on securities with no credit impairment net of tax expense (benefit) of: $201, $(917), and $(594) for the years ended December 31, 2023, 2022 and 2021, respectively | 1,697 | (7,507) | (2,144) |
| Change in unrealized gains (losses) on securities with credit impairment, net of tax expense (benefit) of: $(7), $(1), and $1 for the years ended December 31, 2023, 2022 and 2021, respectively | (26) | (2) | 3 |
| Change in current discount rate related to reserve for future policy benefits, net of tax expense (benefit) of $(41), $361 and $110 for the years ended December 31, 2023, 2022 and 2021, respectively | (146) | 1,303 | 397 |
| Change in non-performance risk on market risk benefits, net of tax expense (benefit) of $(265), $407 and $(92) for the years ended December 31, 2023, 2022 and 2021, respectively | (955) | 1,468 | (332) |
| Total other comprehensive income (loss) | 570 | (4,738) | (2,076) |
| Comprehensive income (loss) | 1,524 | 1,491 | 1,603 |
| Less: Comprehensive income (loss) attributable to noncontrolling interests | 20 | 43 | 262 |
| Comprehensive income (loss) attributable to Jackson Financial Inc. | $1,504 | $1,448 | $1,341 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.